声明：市场有风险，投资需谨慎。本文为AI基于第三方数据生成，仅供参考，不构成个人投资建议。 来源：市场资讯 有投资者在互动平台向傲农生物提问："咨询公司增值税征收方式变动情况：是否由 3% 简易征收改为 13% 一般征收？该调整预计增加的税收成本、对利润的影响金额分别是多少，是否构成重大影响？" 针对上述提问，傲农生物回应称："您好，我司主营业务包括饲料、生猪养殖、屠宰食品，均不涉及您 提及的增值税政策调整。感谢您的关注。" ...

来源：市场资讯 有投资者在互动平台向博雅生物提问："请问公司增值税征收方式是否从 3% 简易征收调整为 13% 一般 征收？本次税率调整预计增加的税收成本是多少？对公司利润影响金额为多少，是否构成重大影响？" 针对上述提问，博雅生物回应称："您好，感谢您对本公司的关注。依据国家增值税的相关政策，血液 制品中的罕见病药物（如PCC、Ⅷ因子及Ⅸ因子等）仍适用3%简易征收，其他血液制品业务不再适用 3%简易征收。公司将根据相关税收政策，积极完善供应链管理举措，做好各项经营管理工作，为公司 和股东创造价值。" 声明：市场有风险，投资需谨慎。本文为AI基于第三方数据生成，仅供参考，不构成个人投资建议。 ...

证券日报网讯 2月24日，上海莱士（002252）在互动平台回答投资者提问时表示，依据国家增值税新 政，血液制品中的罕见病药物仍适用3%简易征收，其他血液制品业务不再适用3%简易征收，该调整属 于行业统一政策。若实行，对行业有一定影响。公司将通过优化采购管理、增强进项抵扣管理力度等合 规方式降低政策变动带来的影响。 ...

来源：市场资讯 针对上述提问，上海莱士回应称："您好！感谢您对我公司的关心和支持！依据国家增值税新政，血液 制品中的罕见病药物仍适用3%简易征收，其他血液制品业务不再适用3%简易征收，该调整属于行业统 一政策。若实行，对行业有一定影响。公司将通过优化采购管理、增强进项抵扣管理力度等合规方式降 低政策变动带来的影响。谢谢。" 声明：市场有风险，投资需谨慎。本文为AI基于第三方数据生成，仅供参考，不构成个人投资建议。 有投资者在互动平台向上海莱士提问："请问公司增值税征收方式是否从 3% 简易征收调整为 13% 一般 征收？本次税率调整预计增加的税收成本是多少？对公司利润影响金额为多少，是否构成重大影响？" ...

Group 1 - The core viewpoint of the article highlights that Luk Fook Holdings (00590) experienced a significant stock price increase, rising over 5% due to the influence of international gold prices on domestic gold jewelry prices [1] - As of January 14, multiple gold jewelry brands in China have raised their domestic gold jewelry prices, surpassing 1435 RMB per gram, with some brands adjusting prices to as high as 1439 RMB per gram on January 15 [1] - Citigroup has initiated a 30-day upward catalyst observation for Luk Fook Holdings, anticipating enhanced operational data for the third quarter of fiscal year 2026 to be released in January [1] Group 2 - The strong sales momentum observed in October and November is expected to continue into December, positively impacting the company's performance [1] - The adjustment in value-added tax policy is projected to lead to robust sales growth, which will positively affect the gross margin for the second half of fiscal year 2026 and the first half of fiscal year 2027 [1]

花旗此前发布研报称，对六福集团开启30天上升催化观察，因预计公司将于1月公布2026财年第三季按 季增强的营运数据；预计10月及11月展现的强劲销售动能将持续至12月；亦认为增值税政策调整后，销 售额强劲增长将对2026财年下半年及2027财年上半年的毛利率产生正面影响。 六福集团(00590)午后涨超5%，截至发稿，涨4.91%，报26.94港元，成交额2319.84万港元。 消息面上，受国际金价带动，国内黄金饰品价格也普遍上涨。据上海证券报报道，1月14日，多家黄金 珠宝品牌公布的境内足金饰品价格继续上调，已突破1435元/克关口。1月15日，多家品牌境内金饰价格 调整出现分歧，较高者已上调至1439元/克。 ...

增值税法和增值税法实施条例自2026年1月1日起施行。其中，增值税法在税收优惠一章中，明确了"医 疗机构提供的医疗服务"免征增值税。增值税法实施条例将前述"医疗机构"定义为"依据有关规定设立的 具有医疗机构执业资格的机构，包括军队、武警部队各级各类医疗机构，不包括营利性美容医疗机 构"。 第一财经记者从国家税务总局北京市税务局12366纳税缴费服务热线处了解到，今年之前增值税相关规 定中，并没有将营利性美容医疗机构排除在上述免税政策范围外。而从今年开始，只要是营利性美容医 疗机构，将不再享受上述免征增值税优惠政策。 [ 葛玉御认为，医美应该适用6%增值税税率。 ] 随着增值税法及其实施条例在今年起实施，医美行业此前部分业务享受免税优惠将成为历史。 比如，根据信用中国等公开信息，2017年1月至2021年11月，杭州古名文化艺术策划有限公司千和医疗 美容诊所为客户提供医疗美容项目服务，利用个人银行账户收取服务款并隐匿服务收入约47.6亿元，未 计入财务账，未对上述收入中的增值税应税项目和免税项目进行分别核算。最终该公司补缴企业所得税 约1.47亿元，并被当地税务罚款约0.88亿元。 目前，增值税税率有三档（6% ...

Core Viewpoint - Citigroup initiates a 30-day upward catalyst observation for Chow Tai Fook (01929), anticipating strong operational performance for Q3 of FY2026 to be announced in January, along with an upward revision of same-store sales growth guidance [1] Group 1: Sales Performance - Following strong performances in October and November, Citigroup expects fixed-price gold product price increases to sustain ideal same-store sales growth in December [1] - The unexpected strong sales following the adjustment of the value-added tax policy is projected to positively impact the group's gross margin for the second half of FY2026 and the first half of FY2027 [1] Group 2: Financial Projections - Citigroup raises net profit forecasts for the group by 8%, 7%, and 6% for FY2026, FY2027, and FY2028 respectively [1] - After a stock price adjustment of over 20% in the past three months, the company is considered attractive with a projected price-to-earnings ratio of 12.8 times and a yield of 6.6% [1] Group 3: Rating and Target Price - Citigroup maintains a "Buy" rating and raises the target price from HKD 17 to HKD 18.2, reflecting the revised earnings forecast [1]

Core Viewpoint - Citigroup has initiated a 30-day upward catalyst observation for Luk Fook Holdings, anticipating strong operational data for Q3 FY2026 to be announced in January [1] Group 1: Sales Performance - Strong sales momentum observed in October and November is expected to continue into December [1] - The adjustment of the value-added tax policy is projected to positively impact gross margins in the second half of FY2026 and the first half of FY2027 due to robust sales growth [1] Group 2: Financial Forecasts - Citigroup has raised its net profit forecasts for Luk Fook for FY2026, FY2027, and FY2028 by 5%, 5%, and 2% respectively [1] - The current valuation of 7.3 times the forecasted price-to-earnings ratio and a dividend yield of 6.2% indicates that the stock remains attractive [1] Group 3: Investment Rating - Citigroup maintains a "Buy" rating for Luk Fook and has increased the target price from HKD 34.6 to HKD 35.2 [1]

Group 1 - The company will hold its third extraordinary general meeting of shareholders on December 18, 2025, at 14:30 in Hohhot, Inner Mongolia [1][9] - Voting will be conducted through a combination of on-site and online methods using the Shanghai Stock Exchange's voting system [1][5] - The network voting will be available on the same day from 9:15 to 15:00, with specific time slots for trading system voting [1][5] Group 2 - The meeting will review several proposals that have been previously approved by the company's board of directors [3][21] - There are no special resolutions or proposals requiring separate voting for minority shareholders [4][19] - Related shareholders, such as Northern United Power Co., Ltd., will abstain from voting on certain proposals [4][21] Group 3 - Shareholders must complete voting for all proposals before submission, and any excess votes will be considered invalid [5][7] - The company has outlined specific registration procedures for shareholders wishing to attend the meeting [11][12] - The meeting is expected to last half a day, with shareholders responsible for their own travel and accommodation costs [13] Group 4 - The company plans to enter into daily related party transactions with China Huaneng Group and its subsidiaries for the years 2026-2028 [20][36] - The expected transaction amounts and categories have been outlined, ensuring compliance with relevant regulations [24][36] - The agreements aim to enhance resource utilization efficiency and do not harm the interests of the company or its shareholders [36][39] Group 5 - The company will sign a framework agreement with China Huaneng Group to govern daily related transactions from January 1, 2026, to December 31, 2028 [29][36] - Financial services will be provided by China Huaneng Financial Co., Ltd., ensuring fair pricing and compliance with market standards [29][33] - The agreements are designed to maintain the company's independence and avoid reliance on related parties [36][39]